Tim McDonough

In a recent report, Mizuho analysts qualify McKesson Corporation (NYSE: MCK)’s purchase of the pharmaceutical distribution division of UDG Healthcare as a “Nice Opportunistic Use of Cash.” The experts rate the stock a Buy, setting a price target of $275.00. Shares of...

Mizuho Securities downgraded Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) from Buy to Neutral and lowered its price target from $37 to $33 in a report issued Friday. On Thursday, Endo Health Solutions Inc (NASDAQ: ENDP) announced it would acquire Auxilium in a $2.6 billion cash and stock...